Proton and Heavy Ion Therapy: An overview
Yüklə 337,22 Kb. Pdf görüntüsü
|
- Bu səhifədəki naviqasiya:
- Table 7 Adaptation of caseload estimates by the UK’s National Proton Beam Therapy Service Development
- Estimated PBT Patients Total Adult Paediatric
- Total AUS/NZ 530 109 638
- Proposed Particle Therapy Facilities in Australia
Proton and Heavy Ion Therapy: An overview: January 2017
23
Table 7 Adaptation of caseload estimates by the UK’s National Proton Beam Therapy Service Development Programme to the 2012 Australian and New Zealand populations Country Estimated Population in 2012 (millions) Estimated PBT Patients Total Adult Paediatric
UK 63.2 1,235
252 1,487
Australia 22.7
444 91
534 New Zealand 4.4 86
18 104
Total AUS/NZ 530 109 638 NB: all figures rounded to nearest whole number More recently, based on evidence arising from Japanese clinical experiences, ANSTO has estimated that 0.02 to 0.04 per cent of the Australian population would benefit from access to particle therapy each year. This equates to approximately 4,800-9,600 patients. As previously stated, greater certainty of domestic patient demand would require an accepted list of particle therapy clinical indications, and subsequent modelling from current and projected Australian and New Zealand cancer incidence and radiotherapy referral rates. This would allow for more accurate determination of facilities required to meet both current and projected demand.
Within Australia, several jurisdictions have indicated interest in establishing PBT and carbon ion facilities, including:
Victoria – as part of the 2015-2016 state budget, the State Government announced $2 million funding to progress planning and development of a National Centre for Proton Beam Therapy as part of the Victorian Comprehensive Cancer Centre (VCCC), undertaken in conjunction with the University of Melbourne and Peter MacCallum Cancer Centre. 51 Subsequently, in August 2016, the Victorian Government announced $50 million for further planning activity, with Parkville nominated as a potential PBT location 52
New South Wales - Westmead Hospital, in conjunction with the University of Sydney and the University of Wollongong have developed a business case for a National Particle Therapy and Research Centre (using carbon ions and protons) to be located at the Westmead Hospital precinct 53
South Australia – South Australia is actively seeking to establish a proton therapy treatment and research centre based at the South Australian Health and Biomedical Precinct
Proton and Heavy Ion Therapy: An overview: January 2017
24
Queensland (public) – the Queensland Metro North Hospital and Health Service have developed a business plan for the potential introduction of a PBT facility at the Royal Brisbane and Women’s Hospital. It is proposed that this facility will be developed in partnership with the University of Queensland, the Queensland Institute of Technology, and Children’s Health Queensland, and
Proton Therapy Australia Pty Ltd to construct a $170 million proton beam facility, 54 and as at October 2016 were seeking equity for land purchase near the Lady Cilento Children’s Hospital, South Brisbane. 55
Memoranda of Understanding to network and integrate their planning activities. This clinician-led collaboration has established links with ANSTO and RANZCR; and internationally with the New Zealand government, the Queen's Medical Research Institute (UK), the European Organization for Nuclear Research (CERN), and with particle centres in the USA, Germany, Denmark, Italy and Japan. The collaboration is additionally seeking to undertake the development of standardised protocols for particle therapy patient selection, treatment, physics, research, education and training as a national collaborative effort, with professional representation through the tripartite committee, the RANZCR, universities, and other relevant bodies, including the State public health systems where appropriate. Should more than one of these proposals progress to construction, there is great risk of considerable expenditure and a potential oversupply of PBT facilities in Australia. It would be considered preferable to have a coordinated, national approach to the introduction of particle therapy to Australia, similar to the process recently undertaken within the UK where planning was commenced in 2008 by the National Health Service. Following development of a strategic outline case, 44
(AU$396) funding for construction of two new PBT facilities in Manchester and London. Facility construction commenced in 2015, with planned completion in 2018 and 2019, respectively. If the current planning within Australia continues in the present manner, PBT is unlikely to be introduced in a coordinated and controlled manner. The establishment of a formal bi-national high-level reference group would provide an appropriate entity to consider and oversee the potential introduction of this technology, with due respect to State and Territory rights. This reference group could include appropriate representatives from the Commonwealth Government, Australian and New Zealand jurisdictions; and relevant scientific, clinical and health consumer entities.
Yüklə 337,22 Kb. Dostları ilə paylaş:
|